Recludix Pharma
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$248M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Recludix Pharma is a biotechnology company that develops innovative small-molecule inhibitors for challenging protein targets to treat cancer and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recludix Pharma Comparables
Compare Recludix Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BridgeBio Pharma, Inc. | 81% | |
| Erasca | 80% | |
| Revolution Medicines | 80% | |
Recludix Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Strategic | Jul 20, 2023 | ||||
| Series A | Nov 15, 2021 |
Key People
Founding team and executive leadership
Recludix Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Series A |
| Westlake Village BioPartners | Series A, Series B |
| New Enterprise Associates (NEA) | Series A, Series B |
| Alexandria Venture Investments | Series B |
| Access Biotechnology | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 49% MoM.
- Mar 16, 2026
Catherine Bovenizer promoted to Chief Financial Officer.
Recludix Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Recludix Pharma's valuation, stock price, and market status.